UOC
DERM

UBS O'Connor’s Dermira, Inc. DERM Stock Holding History

UBS O'Connor’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200,000
Closed -$2.71M – 317
2019
Q1 		$2.71M Buy
+200,000
New +$1.67M 0.08% 138
2016
Q3 		– Sell
-55,443
Closed -$1.62M – 526
2016
Q2 		$1.62M Sell
55,443
-100,957
-65% -$2.79M 0.04% 261
2016
Q1 		$3.23M Buy
+156,400
New +$3.84M 0.03% 286
2015
Q4 		– Sell
-40,400
Closed -$942K – 598
2015
Q3 		$942K Sell
40,400
-159,600
-80% -$3.88M 0.01% 439
2015
Q2 		$3.51M Sell
200,000
-4,400
-2% -$67.9K 0.03% 354
2015
Q1 		$3.14M Buy
204,400
+133,500
+188% +$2.24M 0.03% 341
2014
Q4 		$1.28M Buy
+70,900
New +$1.19M 0.02% 328

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

UBS O'Connor's DERM Position: Q2 2019 in Review

UBS O'Connor sold out of Dermira, Inc. (DERM) in Q2 2019, closing a stake of 200,000 shares — an estimated $2.71M sold.

UBS O'Connor first reported a position in DERM in Q4 2014 and held it in 7 quarters. The position peaked at $3.51M in Q2 2015. 135 funds tracked by Wall St. Rank hold DERM as of Q2 2019.

  • UBS O'Connor reported no remaining Dermira, Inc. position as of Q2 2019 after selling out during the quarter.
  • UBS O'Connor sold 200,000 Dermira, Inc. shares in Q2 2019, an estimated $2.71M.
  • UBS O'Connor first reported a position in Dermira, Inc. in Q4 2014 and held it in 7 quarters.
  • UBS O'Connor's Dermira, Inc. position peaked at $3.51M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2019.

Based on UBS O'Connor's 13F filing for Q2 2019, filed 14 Aug 2019.